About | Free Trial

Last Update

2016-01-21T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Mark Gelder?

Dr. Mark Gelder S. MD

Vice President Clinical Development

Inovio Biomedical Corporation

HQ Phone: (858) 597-6006

Email: m***@***.com

Inovio Biomedical Corporation

10480 Wateridge Circle

San Diego, California 92121

United States

Company Description

Inovio is taking immunotherapy to the next level in the fight against cancer and infectious diseases. We are the only immunotherapy company that is generating T cells in vivo in high quantity that are fully functional and whose killing capacity correlates... more

Find other employees at this company (175)

Background Information

Employment History

Senior Vice President and Chief Medical Officer

Heron Therapeutics Inc

Senior Vice President and Chief Marketing Officer

A.P. Pharma Inc

Vice President of Global Medical Affairs of Oncology

Bayer AG

Vice President, Global Head Medical Affairs and PV, Medical Diagnostics and NPD

GE Healthcare Ltd

Senior Director, Oncology

Wyeth

Education

B.S. degree
biochemistry
Colgate University

M.D.

M.D. degree

University of Virginia's School of Medicine

Web References (83 Total References)


Mark Stephen Gelder , M.D., an ...

ir.inovio.com [cached]

Mark Stephen Gelder , M.D., an experienced gynecologic oncologist, was appointed Vice President, Clinical Development to lead Inovio's clinical development of its immunotherapies against HPV-caused cervical cancer and dysplasia, including our planned phase III study for VGX-3100. Prior to joining Inovio he was Chief Medical Officer at


Heron Therapeutics . A Specialty Pharmaceutical Company • Investor Relations • News Release

phx.corporate-ir.net [cached]

, the Company announced the appointment of Mark S. Gelder, M.D. as Senior Vice President and Chief Medical Officer.


Heron Therapeutics . A Biotechnology Company • Investor Relations • 2012 News Releases

phx.corporate-ir.net [cached]

A.P. Pharma Names Mark S. Gelder, M.D. as Senior Vice President and Chief Medical Officer

...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Dec. 13, 2012-- A.P. Pharma, Inc. (OTCBB: APPA.OB), a specialty pharmaceutical company, today announced the appointment of Mark S. Gelder, M.D. as senior vice president and chief medical officer. The addition of Dr. Gelder to A.P. Pharma’s executive team represents the Company’s continued efforts related to pre-commercialization activities for APF530, the Company’s lead product candidate for the prevention of chemotherapy-induced nausea and vomiting, if app...Â


Heron Therapeutics . A Biotechnology Company • Investor Relations • News Release

phx.corporate-ir.net [cached]

, the Company announced the appointment of Mark S. Gelder, M.D. as Senior Vice President and Chief Medical Officer.


Clinical Research News and Views on the Global Clinical Trials Industry | CenterWatch News Online

www.centerwatch.com [cached]

Inovio Pharmaceuticals appoints Mark Gelder vice president, clinical development

Similar Profiles

Other People with this Name

Other people with the name Gelder

Jay Van Gelder
//www.heartlandsynod.org/

Stephan van Gelder
Integron

Erik van Gelder
DELTA NV

Thomas Gelder
Everett Program

Gideon van Gelder
Gideon Van Gelder

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory